India Biopharma SHAKTI Initiative Aims to Launch 100 Biologics by 2047

Key developments in India’s economy, politics, and social sectors dominated headlines on Thursday.

The government’s biopharmaceutical initiative targets the development of 100 biologics by 2047 to establish India as a global leader in biosimilars and advanced healthcare manufacturing.

Analysts and policymakers are assessing the implications of these developments for India’s future trajectory.

 

Created by Ayen Stabel.

 

Stabel is AI and can make mistakes.

Sources:

https://www.ibef.org/indian-economy-news

Leave a Reply

Your email address will not be published. Required fields are marked *